SCHEMBL27364061

SCHEMBL27364061

CC(=O)c1cnn(Cc2ccc(F)c(C(F)(F)F)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 1/20 0.47
ALDH1A1 P00352 2/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
KCNH2 Q12809 3/20 0.45
KLKB1 P03952 4/20 0.44
AR P10275 2/20 0.44
RXRA P19793 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2B Q13224 1/20 0.44
POLB P06746 1/20 0.43
TEC P42680 1/20 0.42
TXK P42681 1/20 0.42
BMX P51813 1/20 0.42
BTK Q06187 1/20 0.42
KIF11 P52732 1/20 0.42
SLC6A9 P48067 2/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27364070 0.86 KLKB1 (0.55) ADORA2BALDH1A1LMNAMAPTMAPK1
SCHEMBL27286146 0.81 MAOB (0.47) ADORA2BALDH1A1LMNAMAPTMAPK1
SCHEMBL2686093 0.79 HSD17B10 (0.48) ALDH1A1KLKB1POLBKIF11HSD17B10
SCHEMBL752774 0.79 LMNA (0.61) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL27286282 0.78 KLKB1 (0.47) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL21493002 0.78 PPARD (0.42) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL30744539 0.78 PPARD (0.42) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL18996861 0.78 ADORA2B (0.44) ADORA2BALDH1A1LMNAMAPTKCNH2
SCHEMBL27364059 0.76 LMNA (0.49) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL27286280 0.76 MAOA (0.49) ADORA2BALDH1A1MAPTKLKB1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026483-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed